Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000908662-15-000123
Filing Date
2015-03-25
Accepted
2015-03-25 11:55:00
Documents
1
Effectiveness Date
2015-03-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13723
  Complete submission text file 0000908662-15-000123.txt   14786
Mailing Address 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA 02141 617-758-0300
Neurovance, Inc. (Filer) CIK: 0001544176 (see all company filings)

EIN.: 454090332 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-185561 | Film No.: 15723916